BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
FOXP1
,
cell-cell adhesion
,
Allergy to pollen
,
Neuron
,
Nosology
,
Doxorubicin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
retinoblastoma related
Summary
General Info
Curated Studies
Most Correlated Studies
Cancer Gene Census - mutations in cancer genes
GSK cancer cell line transcript profiling
OMIM - Malignant neoplasms
Mouse Phenotypes - Neoplasms
Breast cancer MCF7 cells ER+ with acquired fulvestrant resistance
Explore Curated Studies Results
Literature
Most Relevant Literature
Effect of Ginsenoside Rb2 on a Myocardial Cell Model of Coronary Heart Disease through Nrf2/HO-1 Sig…
Ginsenoside Rb2 improves insulin resistance by inhibiting adipocyte pyroptosis.
Ginsenoside Rb2 alleviates myocardial ischemia/reperfusion injury in rats through SIRT1 activation.
Combination of the ginsenosides Rb3 and Rb2 exerts protective effects against myocardial ischemia re…
Inhibitory role of ginsenoside Rb2 in endothelial senescence and inflammation mediated by microRNA‑2…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Retinoblastoma Biomarker Study
Research on the Environment and Children's Health: Retinoblastoma
Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma
Carboplatin Periocular Injection for Retinoblastoma
Conservative Treatments of Retinoblastoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ